Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the field of biopharmaceuticals, providing promising enhancements throughout several clinical and industrial programs. With its structural similarity to The natural way derived human serum albumin, OsrHSA gives a safer, far more reputable alternative for therapeutic use,